JALC (John Adams Life) Research & Development: $ Mil (TTM As of . 20)


What is John Adams Life Research & Development?

John Adams Life JALC Research & Development is $ Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. John Adams Life's Research & Development for the three months ended in . 20 was $0.00 Mil. John Adams Life does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

John Adams Life  (OTCPK:JALC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

John Adams Life Research & Development Related Terms

John Adams Life Research & Development Historical Data

* Premium members only.

The historical data trend for John Adams Life's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

John Adams Life Research & Development Chart

John Adams Life Annual Data
Trend
Research & Development

John Adams Life Quarterly Data
Research & Development

John Adams Life Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
John Adams Life (JALC) has a Research & Development of $ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on John Adams Life and its competitors.
Is John Adams Life's Research & Development too high?
John Adams Life's current Research & Development is $ Mil.
How does John Adams Life's Research & Development compare to EMGC and AAME?
John Adams Life's Research & Development of $ Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on John Adams Life and its competitors. John Adams Life's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is John Adams Life stock overvalued right now?
John Adams Life (JALC) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For John Adams Life (JALC), the current Research & Development is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

John Adams Life Business Description

Address 5776 Lindero Canyon Road, Suite D-417, Westlake Village, CA, USA, 91362
John Adams Life Corp is a us-based company. The company is continuing to explore opportunities for mergers and acquisitions in its business of offering financial services to individuals and businesses. The company's source of revenue is Investment Income, Realized gains(loss) on investment, and Commissions.